Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Net Income (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Net Income for 17 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • Quarterly Net Income rose 1328.95% to $1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.1 billion through Dec 2025, up 178.99% year-over-year, with the annual reading at $7.1 billion for FY2025, 178.99% up from the prior year.
  • Net Income for Q4 2025 was $1.1 billion at Bristol Myers Squibb, down from $2.2 billion in the prior quarter.
  • The five-year high for Net Income was $2.5 billion in Q1 2025, with the low at -$11.9 billion in Q1 2024.
  • Average Net Income over 5 years is $976.1 million, with a median of $1.6 billion recorded in 2022.
  • The sharpest move saw Net Income soared 1426.25% in 2021, then tumbled 625.28% in 2024.
  • Over 5 years, Net Income stood at $2.4 billion in 2021, then fell by 14.63% to $2.0 billion in 2022, then fell by 12.99% to $1.8 billion in 2023, then tumbled by 95.69% to $76.0 million in 2024, then surged by 1328.95% to $1.1 billion in 2025.
  • According to Business Quant data, Net Income over the past three periods came in at $1.1 billion, $2.2 billion, and $1.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.